CMS Ambulatory Blood Pressure Monitoring Coverage Policy Update (NCD 254)
CMS has issued a modification to National Coverage Determination 254, governing Ambulatory Blood Pressure Monitoring (ABPM) for Medicare beneficiaries. If your practice diagnoses or manages hypertension in Medicare patients, this policy directly affects when and how you can bill for ABPM services. Here's what changed, what the coverage criteria require, and exactly what your billing team needs to do.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Ambulatory Blood Pressure Monitoring |
| Policy Code | NCD 254 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | Medium |
| Specialties Affected | Cardiology, Nephrology, Internal Medicine, Family Medicine, Primary Care |
| Key Action | Review and confirm your ABPM documentation protocols meet NCD 254's specific BP threshold criteria for both white coat and masked hypertension before billing. |
What Is CMS Covering Under NCD 254 for Ambulatory Blood Pressure Monitoring?
The Centers for Medicare & Medicaid Services covers ABPM as a diagnostic test under the Diagnostic Tests (other) benefit category. ABPM involves a small portable device connected to a blood pressure cuff that records BP readings at regular intervals over 24 to 48 hours — capturing data during normal daily activities and sleep. A physician or non-physician practitioner (NPP) must interpret the recording and direct subsequent care.
Coverage under NCD 254 applies to Medicare beneficiaries for hypertension diagnosis under two distinct clinical indications: suspected white coat hypertension and suspected masked hypertension. Both indications have precise, numeric BP thresholds that must be documented in the medical record. If those thresholds aren't met and documented, the claim lacks medical necessity support — and that's where denials happen.
The policy has been in effect for dates of service on and after July 2, 2019, with this modification reflecting the March 2026 review cycle.
CMS Medical Necessity Criteria for ABPM: White Coat vs. Masked Hypertension
Understanding the difference between covered indications is critical to avoiding denials. These aren't interchangeable — each has its own numeric parameters.
Suspected White Coat Hypertension
White coat hypertension is covered when ALL of the following are documented:
| # | Covered Indication |
|---|---|
| 1 | Average office BP of systolic >130 mm Hg but <160 mm Hg, **or** diastolic >80 mm Hg but <100 mm Hg |
| 2 | Measured on two separate clinic or office visits, with at least two separate measurements per visit |
| 3 | At least two BP measurements taken outside the office that are <130/80 mm Hg |
The clinical picture here is straightforward: BP appears elevated in a clinical setting but is normal outside it. ABPM confirms the pattern before a hypertension diagnosis is made.
Suspected Masked Hypertension
Masked hypertension is covered when ALL of the following are documented:
| # | Covered Indication |
|---|---|
| 1 | Average office BP between 120 mm Hg and 129 mm Hg for systolic, or between 75 mm Hg and 79 mm Hg for diastolic |
| 2 | Measured on two separate clinic or office visits, with at least two separate measurements per visit |
| 3 | At least two BP measurements taken outside the office that are ≥130/80 mm Hg |
This is the inverse scenario — BP appears normal in the office but is elevated in real-world conditions. Masked hypertension is notoriously underdiagnosed, and ABPM is the mechanism CMS recognizes for catching it.
ABPM Device and Testing Requirements Under CMS NCD 254
Coverage isn't just about patient eligibility — it also requires the ABPM device itself and the testing process to meet specific standards. CMS requires all three of the following:
- Device capability: The ABPM device must produce standardized plots of BP measurements for 24 hours, with daytime and nighttime windows and normal BP bands clearly demarcated.
- Patient instruction: Patients must receive both oral and written instructions, and a test run must be performed in the physician's office before the patient leaves with the device.
- Interpretation by treating provider: Only the treating physician or treating NPP may interpret the results. Outsourcing interpretation to a non-treating provider does not satisfy this requirement.
Each of these is a potential audit target. If your documentation doesn't reflect that a test run was performed in-office or that written instructions were provided, you're exposed.
Frequency limitation: ABPM is covered once per year for eligible patients. Billing beyond that frequency without documentation of a new qualifying indication will result in denial.
Non-Covered Indications and MAC Discretion
CMS does not designate any nationally non-covered indications under NCD 254. However, that doesn't mean all ABPM use is automatically covered.
Any ABPM indication not explicitly listed above — meaning conditions or clinical scenarios beyond white coat or masked hypertension — falls to Medicare Administrative Contractor (MAC) discretion. Your regional MAC may have a Local Coverage Determination (LCD) that addresses those scenarios. If you're billing ABPM for indications outside the two covered categories, you need to check your MAC's LCD before submitting claims.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The policy data for NCD 254, as published, does not list specific CPT or HCPCS codes. Contact your MAC or billing clearinghouse to confirm the current procedure codes used to bill ABPM services in your region, and verify those codes are mapped correctly to this NCD in your practice management system.
No ICD-10-CM diagnosis codes are specified in the policy data for NCD 254.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit your ABPM documentation templates immediately. Before the March 12, 2026 effective date, confirm that your intake and visit documentation templates capture all required elements: two separate office visits, two readings per visit, and at least two out-of-office BP readings. If your EHR templates don't prompt for this, flag it for your clinical informatics team now. |
| 2 | Verify your MAC's LCD for non-covered indications. If your providers order ABPM for reasons beyond white coat or masked hypertension, pull your MAC's current LCD for ABPM before billing. Submitting under NCD 254 for an indication that requires MAC-level review — without that review — is a fast path to a denial or take-back. |
| 3 | Flag the once-per-year frequency limit in your billing system. Build a hard stop or edit in your practice management or billing platform that flags ABPM claims for the same beneficiary within a 12-month period. Frequency-based denials are among the easiest to prevent with the right system configuration. |
| 4 | Confirm device documentation is in the chart. For every ABPM claim, the record should reflect the device's capability (24-hour standardized plots with daytime/nighttime windows), that a test run was completed in-office, and that both oral and written instructions were given. Add a pre-billing documentation checklist if your team doesn't already use one. |
| 5 | Confirm the interpreting provider is the treating provider. If your practice uses a workflow where a different clinician reads ABPM results, that arrangement does not satisfy NCD 254's requirement. Only the treating physician or treating NPP interpretation supports a covered claim. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.